NIPER Raebareli, AstraZeneca partner to expand clinical trials to 25 emerging hubs

IANS | October 14, 2026 3:54 PM

New Delhi, Oct 14 (IANS) The National Institute of Pharmaceutical Education and Research (NIPER), Raebareli and AstraZeneca India have collaborated to expand clinical trial capabilities beyond metros to strengthen India's clinical research capabilities and increase the country's participation in global clinical trials, according to an official statement released on Wednesday.

Centre to cap trade margins on cancer drugs, SC calls for broader price review

IANS | October 12, 2026 4:36 PM

New Delhi, Oct 12 (IANS) The Centre on Monday informed the Supreme Court that it has decided to regulate trade margins on anti-cancer medicines by capping them at 30 per cent of the maximum retail price (MRP), while the apex court called for a broader review of medicine pricing across the pharmaceutical sector.

Centre asks states, UTs to ensure hospitals display treatment charges prominently

IANS | October 12, 2026 1:55 PM

New Delhi, Oct 12 (IANS) The Union Ministry of Health and Family Welfare on Monday asked all States and Union Territories (UTs) to ensure that clinical establishments prominently display the rates charged for healthcare services and facilities, in a move aimed at enhancing transparency, accountability and patient-centric healthcare delivery.

Govt approves Rs 86 crore support for Peptris’ AI-driven drug development programme

IANS | October 12, 2026 1:39 PM

New Delhi, Oct 12 (IANS) The Technology Development Board (TDB) -- under the Department of Science and Technology (DST) -- has signed an agreement with Peptris Technologies Pvt Ltd to provide financial support of Rs 86 crore under the Research Development and Innovation (RDI) Fund for an AI-led drug development programme, according to an official statement on Monday.